IDYA
Ideaya Biosciences Inc
NASDAQ: IDYA · HEALTHCARE · BIOTECHNOLOGY
$28.05
-3.41% today
Updated 2026-04-29
Market cap
$2.46B
P/E ratio
—
P/S ratio
11.26x
EPS (TTM)
$-1.28
Dividend yield
—
52W range
$17 – $39
Volume
1.3M
Ideaya Biosciences Inc (IDYA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $19.54M | $27.94M | $50.93M | $23.39M | $7.00M | $218.71M |
| Revenue growth (YoY) | — | — | — | — | +43.0% | +82.3% | -54.1% | -70.1% | +3024.4% |
| Cost of revenue | $391000.00 | $886000.00 | $1.25M | $39.70M | $1.73M | $2.10M | $4.01M | $3.83M | $4.59M |
| Gross profit | $-391000.00 | $-886000.00 | $-1.25M | $19.54M | $27.94M | $50.93M | $19.38M | $3.17M | $214.12M |
| Gross margin | — | — | — | 100.0% | 100.0% | 100.0% | 82.9% | 45.2% | 97.9% |
| R&D | $12.38M | $31.75M | $34.32M | $39.70M | $58.16M | $89.54M | $129.51M | $294.67M | $314.70M |
| SG&A | $2.05M | $4.67M | $9.95M | $15.18M | $20.05M | $23.90M | $28.31M | $39.30M | $63.32M |
| Operating income | $-14.44M | $-36.42M | $-44.27M | $-35.34M | $-50.27M | $-62.50M | $-134.43M | $-326.98M | $-159.31M |
| Operating margin | — | — | — | -180.9% | -179.9% | -122.7% | -574.9% | -4671.1% | -72.8% |
| EBITDA | $-11.47M | $-33.46M | $-43.03M | $-33.96M | $-48.54M | $-60.40M | $-108.95M | $-270.64M | $-154.72M |
| EBITDA margin | — | — | — | -173.8% | -173.7% | -118.6% | -465.9% | -3866.3% | -70.7% |
| EBIT | $-11.86M | $-34.35M | $-44.27M | $-35.34M | $-50.27M | $-62.50M | $-112.96M | $-274.48M | $-159.31M |
| Interest expense | $0.00 | $0.00 | $0.00 | $849000.00 | $506000.00 | $3.85M | $21.47M | — | — |
| Income tax | $-150000.00 | $2.07M | $-3.53M | $-2.23M | $-2.23M | $-3.85M | $3.84M | — | — |
| Effective tax rate | 1.2% | -6.4% | 8.4% | 6.5% | 4.5% | 6.6% | -3.5% | 0.0% | 0.0% |
| Net income | $-11.86M | $-34.35M | $-38.44M | $-32.27M | $-47.53M | $-54.81M | $-112.96M | $-274.48M | $-113.70M |
| Net income growth (YoY) | — | -189.5% | -11.9% | +16.1% | -47.3% | -15.3% | -106.1% | -143.0% | +58.6% |
| Profit margin | — | — | — | -165.1% | -170.1% | -107.6% | -483.0% | -3921.1% | -52.0% |